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0.2±1.2 METs, p<0.05).
Conclusions: Responders of LV reverse remodeling predicts a lower heart failure event
rate than non-responders. They were also associated with more symptomatic improve-
ment and a better gain in peak exercise capacity.
1111-224 Improvement of Brain Natriuretic Peptide Levels 48 
Hours Following Cardiac Resynchronization Therapy
Nazim U. Khan, David W. Frazier, Srivani R. Ambati, Jaafer Golzar, Martha Clutter, Paul 
W. Vos, Harry J. DeAntonio, Assad Movahed, East Carolina University, Brody School of 
Medicine, Greenville, NC
Background: Brain natriuretic peptide (BNP) levels are a marker of left ventricular dys-
function in heart failure. High BNP levels after optimal medical management of heart fail-
ure are an independent predictor of prognosis. Cardiac resynchronization therapy (CRT)
or dual ventricular chamber pacing improves quality of life, exercise capacity and cardiac
function. A small previous study showed improvement in BNP levels with chronic CRT
(15±8 weeks). We investigated the short term effects of CRT on BNP levels.
Methods: 36 patients with a mean EF 23±7% and LBBB (mean QRS 170±25ms) were
investigated. BNP levels were checked immediately prior to and 48 hours after CRT. BNP
levels were measured using the Triage BNP test/ Biosite Diagnostics, USA.
Results: The paired t-test on the log transformed data indicates that the difference
between baseline BNP and 48 hours BNP is statistically significant (p=0.0006). The aver-
age change on the log scale is –0.3956 which is 0.673 when converted to a proportion.
The 95% confidence interval for the average change is 0.545-0.832. The figure shows
the ratios of 48 hours/baseline BNP levels plotted in increasing order of the ratio, for the
36 patients. 75% of the patients had a reduction in BNP.
Conclusions: There is a statistically significant reduction in BNP levels 48 hours follow-
ing CRT. 
1111-225 In the Rapid Pacing Canine Model of Heart Failure, Left 
Ventricular Stimulation Resynchronizes Better the Left 
Ventricle Compared to Biventricular or Right Ventricular 
Stimulation: An Echocardiographic-Hemodynamic 
Correlation of Systolic and Diastolic Function
Bernard Thibault, Anique Ducharme, Yan-Fen Shi, Marc Dubuc, Peter Guerra, Laurent 
Macle, Denis Roy, Mario Talajic, Jean-Claude Tardif, Institut de Cardiologie de Montréal, 
Montreal, PQ, Canada
Resynchronization therapy is effective for patients with left ventricle (LV) dysfunction, but
the underlying mechanisms are not well understood. We studied acute hemodynamic
effects of RV, LV and biventricular (BiV) and established the correlation with LV resyn-
chronization assessed with echocardiography and tissue Doppler. Methods: A total of 17
dogs were paced at high rate for a minimum of 4 weeks to create LV dysfunction. Trans-
venous pacing electrodes were implanted in the right atrium, the right ventricle (RV) and
in a lateral branch of the coronary sinus (LV). Aortic, LV and pulmonary pressure were
continuously monitored and because dogs have short PR intervals, complete AV node
ablation was performed to assess the isolated effect of the different modes of stimulation,
with no participation of intrinsic conduction. Results: All the animals developed severe
heart failure (mean LVEF=28,7%), none with a wide QRS. LV stimulation was associated
with better LV hemodynamic parameters than BiV (5-10%)which was superior to RV stim-
ulation (10-20%, p<0.05). Echocardiographic evaluation showed that LV pacing was
associated with improved LVEF, less mitral regurgitation (MR) and less LV intraventricular
dyssynchrony as assessed with tissue Doppler. Improved systolic performance was
associated with improved diastolic performance (negative Lvdpdt) and diastolic pattern
assessed by echo. Conclusions: 1- In a canine model of heart failure, LV stimulation was
found to result in better LV systolic and diastolic performance compared to BiV and RV
stimulation. 2- The superior LV performance with LV pacing is associated with improved
LVEF, less mitral regurgitation and less intraventricular systolic and diastolic LV dyssyn-
chrony.
1111-226 Frequency and Mechanisms of Inappropriate 
Implantable Cardioverter Defibrillator Therapy in MADIT 
II
James P. Daubert, Wojciech Zareba, David S. Cannom, Claudio D. Schuger, Paul Wang, 
Mark L. Andrews, Jackson Hall, Arthur J. Moss, University of Rochester Medical Center, 
Rochester, NY
Background: Inappropriate implantable defibrillator (ICD) shocks have been reported to
be a common adverse event in ICD patients, with serious consequences including
impaired quality of life. Methods: We classified the rhythm triggering ICD therapy by
review of stored electrograms for each episode. Inappropriate therapy was defined as
antitachycardia pacing or ICD shock for anything other than ventricular arrhythmia. Inap-
propriate shocks were further classified as atrial fibrillation (AF), other supraventricular
tachycardia (SVT) (including sinus), or abnormal sensing. We examined the baseline
clinical characteristics and medications of patients with and without inappropriate shocks.
Results: Inappropriate shocks occurred in 88 (12.2 %) of the 720 patients who received
an ICD in MADIT II. A total of 806 therapies were delivered from the ICD of which 513
(63.6%) were appropriate and 293 (36.4%) were inappropriate. The clinical characteris-
tics of patients receiving inappropriate therapy were not different from those patients not
receiving such therapy. Conclusions: Despite awareness of the frequency of inappropri-
ate therapy in prior ICD trials, and despite frequent use of detection algorithms, inappro-
priate ICD therapy was common in the MADIT II trial. The most common mechanism for
inappropriate shocks in the MADIT II trial was AF. Clinical characteristics and medica-
tions prescribed do not predict which patients experience inappropriate ICD therapy.
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828-1 Pulmonary Vein Isolation to Prevent Atrial Fibrillation: 
Long-Term Safety, Efficacy, and Predictors of Outcome
Hakan Oral, Aman Chugh, Burr W. Hall, Peter Cheung, Srikar Veerareddy, Kristina 
Lemola, Jihn Han, Kamala Tamirisa, Frank Pelosi, Jr., Fred Morady, University of 
Michigan, Ann Arbor, MI
Background: The long-term safety and efficacy of segmental ostial ablation to isolate
the pulmonary veins in patients with atrial fibrillation (AF) have not been well-
defined.Methods and Results: Pulmonary vein isolation by ostial applications of radiof-
requency energy guided by pulmonary vein potentials was performed in 187 consecutive
patients (mean age = 52 ± 11 years) with paroxysmal (167) or persistent AF (20). The left
superior, left inferior, and right superior pulmonary veins were targeted in all patients, and
the right inferior pulmonary vein also was targeted in 73 patients (39%). Successful isola-
tion was achieved in 96% of targeted pulmonary veins. A repeat ablation procedure was
performed in 11% of the patients. At 2 years of follow up, 70% of patients with paroxys-
mal AF and 25% of patients with persistent AF were free of recurrent episodes of AF, in
the absence of antiarrhythmic drug therapy (p<0.001). Among patients with paroxysmal
AF, vagotonic AF was the only independent predictor of recurrent AF. Complications con-
sisted of pericardial tamponade (0.5%), left atrial flutter (0.5%), transient ischemic attack
(0.5%), and unilateral quadrantopsia (0.5%). No patient had symptomatic pulmonary vein
stenosis. Conclusions: The long-term efficacy of pulmonary vein isolation is 70% in
patients with paroxysmal AF, and the risk of complications is low. Alternative ablation
strategies should be considered to improve long-term efficacy, particularly in patients
with persistent or vagotonic AF.
Inappropriate Therapy
Type Frequency
AF 131 (48%)
Other SVT 96 (34 %)
Abnormal Sensing 48 (17 %)
